Robert J Lewandowski

Robert J Lewandowski is a Professor of Radiology (Vascular and Interventional Radiology), Medicine (Hematology and Oncology), and Surgery at Northwestern University's Feinberg School of Medicine. He leads clinical trials focusing on radioembolization therapies for liver cancers and is affiliated with the Robert H. Lurie Comprehensive Cancer Center and Northwestern University Clinical and Translational Sciences Institute (NUCATS). His work emphasizes loco-regional treatments for primary/secondary liver cancers and IVC filter applications in venous thromboembolism.

Education:

• MD: Michigan State University (1999)
• Residency: William Beaumont Hospital (2005)
• Fellowship: Northwestern University McGaw Medical Center (2006)

Research Interests: Innovations in Yttrium-90 radioembolization, optimizing liver resection outcomes, and combining therapies for metastatic cancers. His studies address dose optimization, liver hypertrophy prediction, and safety of therapies for unresectable hepatocellular carcinoma.

Clinical Trials:

• Yttrium-90 Radiation Lobectomy (NCT04390724)
• EMERALD-Y90 Phase II Study (NCT06040099)

Awards: Recognized for editorial contributions (JVIR), mentorship, and peer review excellence. Holds leadership roles in SIR, including President (2024-2025).

Professional Service: Editorships in Cancers, Seminars in Interventional Radiology, and multiple journals. Active reviewer for high-impact publications like Lancet Oncology and Circulation.